3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
3
Pancreatic Neoplasms
2
Uterine Neoplasms
1
Uterine Hemorrhage
1
Uterine Diseases
1
Postoperative Nausea and Vomiting
1
Postoperative Complications
1
Pancreatic Adenocarcinoma
1
Pain, Postoperative
1
Multiple Pulmonary Nodules
1
Lung Neoplasms
1
Liver Neoplasms
1
Leiomyoma
1
Hypotension
1
Cognitive Dysfunction
1
Chronic Pain
1
Breast Carcinoma In Situ
1
Agnosia
1
Acute Pain
1
Interventions
pembrolizumab
14
Nivolumab
11
Ipilimumab
10
cabozantinib
6
Axitinib
6
belzutifan
5
Radiosurgery
5
atezolizumab
4
Sunitinib
4
palbociclib
3
lenvatinib
3
Surveys and Questionnaires
3
Radiotherapy
3
Pluvicto
3
Everolimus
3
Blood Specimen Collection
3
Biopsy
3
zimberelimab
2
pazopanib
2
cemiplimab
2
Therapeutics
2
Methods
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
trebananib
1
toripalimab
1
tocilizumab
1
temsirolimus
1
spartalizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Anesthesia, General
×
1 year
×
Clear all
No trials found.